Ellipticine inhibits p53 protein phosphorylation by a selective inhibition of CDK2 kinase in Lewis lung carcinoma and the human colon cancer cell line SW480 [11], and this effect on p53 correlated with cytotoxic activity of ellipticine [11]. Here, TP53 is linked to malignant colon neoplasm.